A concise update on how AI is reshaping dermatopathology, its strengths for melanoma and common lesions, limits with rare diseases, and the path to safe clinical adoption.
AI in Skin Diagnostics: What Clinicians and Investors Need to Know Read More »
The UK can lead AI healthcare regulation with lifecycle rules, a high-risk tier, assurance cases and an AI Yellow Card to protect patients and speed adoption.
UK’s Urgent Opportunity: Shaping World-Class AI Regulation in Healthcare Read More »
How AI is applied to Traditional Chinese Medicine: tongue scanners, pulse readers, molecular mapping, and government-backed expansion, with limits and human oversight.
AI and Traditional Chinese Medicine: Diagnostics, Research, and Limits Read More »
A concise reality check on how patients experience AI in NHS care, the risks users face, administrative gaps, accessibility issues, and five guiding principles for safe deployment.
AI in the NHS: Public Experiences and the Road to Responsible Integration Read More »
Insilico Medicine and Qilu Pharmaceutical launched a strategic collaboration using Chemistry42 and Biology42 to discover cardiometabolic drug candidates. Read a concise analysis of what this deal means for AI adoption in pharma.
NHS launches a pilot using AI to detect lung nodules and robotics to guide biopsies. Read how the tech works and what it could mean for earlier cancer diagnosis.
Insilico Medicine and Qilu Pharmaceutical launch an AI-driven collaboration worth up to $120M to discover small molecules for cardiometabolic diseases.
Insilico and Qilu Forge $120M AI Alliance to Target Cardiometabolic Disease Read More »
How AI is improving early cancer detection: boosting FIT test accuracy, refining risk models, and reducing regional disparities for earlier intervention.
AI’s Impact on Early Cancer Detection: From Better FIT Results to Fairer Care Read More »
How AI diagnostics improve early detection, diagnostic accuracy and predictive analytics to lower readmissions, optimize hospital resources and support personalized care.
AI Diagnostics: Revolutionizing Early Detection and Patient Care Read More »
Tandem Health acquires Dutch speech AI startup Juvoly to cut clinician admin time, scale proven voice-controlled documentation across Europe, and keep data on Dutch servers.
Juvoly Joins Tandem Health: Speech AI Merger to Scale AI Healthcare Across Europe Read More »
